EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/31/2026
Back to search
Official data from USPTO
IMMUDEX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
IMMUDEX
ST13
US500000088019409Class
1, 5, 42
Filing
88019409
Registration
6031798
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
07/31/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
06/28/2018
Registration date
04/14/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/06/2026
Last transaction
07/31/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
16
Owner location
Virum, DK
Examiner
PHILLIPS, WENDELL SHARMAN
Current location
Historical data usage
Holders and representatives
Holders
I. A. (pessoa física)
I. A. (pessoa física)
Representatives
Miriam D. Trudell Davis Graham & Stubbs LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in diagnosticsindustry and scienceother than for medical or veterinary purposes; diagnostic and research reagents for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic test materials for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes; diagnostic kits for scientific and diagnostic purposes other than medical or veterinary diagnostic purposes consisting primarily of MHC multimer reagentsmonoclonal antibodiesreagentsdiagnostic agentscontrol reagentsDNA/RNA oligo's and DNA/RNA oligo conjugated reagents; assays for research and diagnostic purposes other than medical or veterinary diagnostic purposes; biochemical reagents used for non-medical purposes; chemical preparations for analysis for research purposes related to vaccines and immunotherapycancer vaccinesborrelia vaccinesTB-vaccinesHIV-vaccinesCMV-vaccines and other vaccinesfor analysis for research purposes of T-cell lymphomaT-cell infiltration of solid tumors and tissuefor analysis for research purposes of infectious diseasesautoimmunity and for use in connection with toxicological studies and research in relation to transplantationimmune monitoringvaccines and T-cell monitoring; chemical reagents other than for medicinal and veterinary purposes
Class 5
Preparations for pharmaceutical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; preparations for medical purposes for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; chemical-pharmaceutical preparations for treatment of cancerT-cell lymphomaT-cell infiltration of solid tumors and tissueT-cell diseases in bloodtransplantation related diseases and diseases related to immune suppressionautoimmune disease and infectious diseases; diagnostic preparations for medical purposes; reagents for medical and veterinary purposes; vaccines; chemical preparations for analysis for medical diagnostic purposes in relation to vaccinesimmunotherapeutics and cellular therapiesincluding cancer vaccines and immunotherapeuticsborrelia vaccinesTB-vaccinesHIV-vaccines and CMV-vaccinesT-cell therapiesfor use in connection with cancer therapy and other medical therapiesfor analysis and treatment o T-cell lymphomaT-cell infiltration of solid tumors and tissuefor infectious diseasesfor use in connection with medical procedures and diagnosisnamely transplantationimmune monitoringvaccines and T-cell monitoring
Class 42
Scientific research services; diagnostic services related to scientific research; basic research and clinical research in relation to medicine and vaccine development; research and development in the field of diagnostic preparations
Publications
History of USPTO decisions and trademark events.
59 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/31/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/31/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/31/2026
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
07/06/2026
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/06/2026
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/06/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/29/2026
E815
TEAS SECTION 8 & 15 RECEIVED
03/31/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/14/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/12/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/12/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/12/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/14/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/14/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/14/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/14/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/14/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/14/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/16/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/16/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/16/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/16/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/16/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/12/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/12/2021
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/12/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/12/2021
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/12/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/12/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
04/14/2020
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
03/11/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
03/11/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/14/2020
PUBO
PUBLISHED FOR OPPOSITION
01/14/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/07/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
11/22/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/24/2019
GNFR
FINAL REFUSAL E-MAILED
05/24/2019
CNFR
FINAL REFUSAL WRITTEN
05/24/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/06/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/06/2019
ALIE
ASSIGNED TO LIE
05/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/25/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/25/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/25/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/26/2018
GNRT
NON-FINAL ACTION E-MAILED
10/26/2018
CNRT
NON-FINAL ACTION WRITTEN
10/26/2018
DOCK
ASSIGNED TO EXAMINER
10/18/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/03/2018
NWAP
NEW APPLICATION ENTERED
07/02/2018
Continuous trademark protection
Get notified about every new filing that threatens IMMUDEX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.